Skip to content
healthcare.dev
Get a free key

Lamivudine

NDC 57237-274, Lamivudine, solution, from Rising Pharma Holdings, Inc..

Product NDC
57237-274
Status
Listed
Labeler
Rising Pharma Holdings, Inc.
Dosage form
SOLUTION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA077695
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/57237-274 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LAMIVUDINE10 mg/mL

Pharmacologic classes

Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Nucleoside Reverse Transcriptase Inhibitors [MoA]

Package NDCNDC-11Package
57237-274-2457237027424240 mL in 1 BOTTLE (57237-274-24)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/bed2e227-8d36-40ea-bbbf-d8793bfda425

  • NADAC price for package 57237027424

    GET /v1/drugs/nadac/57237027424

Use it

Look up 57237-274 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/57237-274 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 57237-274. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.